The Food and Drug Administration (FDA) has approved Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Findings showed concizumab-treated patients had an 86% reduction in annual bleeding rate compared with no prophylaxis. The Food and Drug Administration (FDA) has approved Alhemo ® (concizumab-mtci) ...

CBD did not meet primary end point comparing preingestion to postingestion anxiety, but resulted in lower anxiety levels ...

The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

(HealthDay News) — Light-to-moderate consumption of wine, measured through an objective urinary biomarker, is associated with lower cardiovascular disease (CVD) risk in an older Mediterranean ...

(HealthDay News) — The use of influenza testing at hospital emergency department visits increased from 2013 to 2022 in the United States, according to a December data brief published by the National ...

Results from the VENTURE trial showed significant reductions in weight and hunger among younger patients treated with ...

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

Potassium (as chloride) 10mEq, 20mEq. Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis ...

Pyridoxine 25mg, folic acid 1mg, Vit. C 120mg, Vit. D3 400 IU, calcium (as citrate) 120mg, iron (as carbonyl + ferrous gluconate) 20mg; tabs. Pyridoxine HCl (Vit. B6 ...

GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. Approved in 2023, Jesduvroq, (HIF-P ...

Lansoprazole 15mg; e-c delayed-release granules in caps. Trouble or pain swallowing food. Vomiting with blood. Bloody or black stools. Chest or shoulder pain with shortness of breath; sweating ...